Baxter International Inc. (BAX)

82.99
0.34 0.41
NYSE : Health Technology
Prev Close 82.65
Open 82.50
Day Low/High 82.33 / 83.93
52 Wk Low/High 61.05 / 82.85
Volume 2.62M
Avg Volume 2.41M
Exchange NYSE
Shares Outstanding 510.17M
Market Cap 41.87B
EPS 3.00
P/E Ratio 27.91
Div & Yield 0.88 (0.96%)

Latest News

Baxter Highlights Progress Toward Its 2020 Corporate Responsibility Goals And Efforts To Make A Meaningful Difference Around The World

Baxter Highlights Progress Toward Its 2020 Corporate Responsibility Goals And Efforts To Make A Meaningful Difference Around The World

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today the release of its 2018 Corporate Responsibility Report, which showcases the company's progress on key initiatives to drive more sustainable operations,...

Baxter Highlights Renal Care Data About Patients' Health-Related, Quality Of Life Outcomes At The 56th ERA-EDTA Congress

Baxter Highlights Renal Care Data About Patients' Health-Related, Quality Of Life Outcomes At The 56th ERA-EDTA Congress

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, showcased 19 data presentations on therapy options at the 56 th ERA-EDTA Congress, Budapest, Hungary, June 13-16.

Baxter Leads Hemodialysis Research Consortium For German Federal Ministry Of Education And Research

Baxter Leads Hemodialysis Research Consortium For German Federal Ministry Of Education And Research

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced receipt of a major research and development (R&D) grant from the German Federal Ministry of Education and Research (BMBF)'s "From Material to Innovation" program to...

Baxter To Host Second Quarter 2019 Financial Results Conference Call For Investors

Baxter To Host Second Quarter 2019 Financial Results Conference Call For Investors

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its second quarter 2019 financial results on Thursday, July 25, 2019, at 7:30 a.

Baxter Launches The Sharesource 2.0 Clinical Portal To Give Healthcare Providers Greater Insights To Their Patients' Home Peritoneal Dialysis Treatments, While Offering Improved Clinic Workflow. (Photo: Business Wire)

Baxter Launches The Sharesource 2.0 Clinical Portal To Give Healthcare Providers Greater Insights To Their Patients' Home Peritoneal Dialysis Treatments, While Offering Improved Clinic Workflow. (Photo: Business Wire)

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today the launch of the Sharesource 2.

The Baxter International Foundation Commits $2 Million To Operation Smile Care Centers In India

The Baxter International Foundation Commits $2 Million To Operation Smile Care Centers In India

The Baxter International Foundation, the philanthropic arm of Baxter International Inc.

Baxter Announces New Research On 3-in-1 Oxiris Set For CRRT And Sepsis Management

Baxter Announces New Research On 3-in-1 Oxiris Set For CRRT And Sepsis Management

Baxter International Inc. (NYSE: BAX), a global leader in acute care therapies, announced today that the peer-reviewed journal Blood Purification published a supplemental issue sponsored by Baxter that features real-world clinical experience with the...

Baxter To Conduct Fixed Income Investor Presentations

Baxter To Conduct Fixed Income Investor Presentations

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that representatives of the company will conduct a series of Fixed Income Investor Presentations on Thursday, May 9, 2019.

Baxter Named A "Best Company For Multicultural Women" By Working Mother

Baxter Named A "Best Company For Multicultural Women" By Working Mother

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today that it has been named a 2019 Best Company for Multicultural Women by Working Mother magazine.

Baxter Increases Dividend And Declares Quarterly Dividend

Baxter Increases Dividend And Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced an increase in the company's quarterly cash dividend, to a rate of $0.

Baxter To Present At The UBS Global Healthcare Conference

Baxter To Present At The UBS Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the UBS Global Healthcare Conference on Monday, May 20, 2019 in New York.

Baxter, NAACP And The Alliance For Home Dialysis Expand Program To Increase Awareness Of Kidney Care Among African Americans

Baxter, NAACP And The Alliance For Home Dialysis Expand Program To Increase Awareness Of Kidney Care Among African Americans

Baxter International Inc. (NYSE:BAX), a global leader in renal care, along with the National Association for the Advancement of Colored People (NAACP) and the Alliance for Home Dialysis, today announced that the Dialysis Health Imperative for Access,...

Baxter Reports First-Quarter 2019 Results

Baxter Reports First-Quarter 2019 Results

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the first quarter of 2019 and increased its full-year 2019 earnings outlook.

Baxter To Present At The Bank Of America Merrill Lynch Health Care Conference 2019

Baxter To Present At The Bank Of America Merrill Lynch Health Care Conference 2019

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 2019 Bank of America Merrill Lynch Health Care Conference in Las Vegas on May 15, 2019.

Baxter Unveils The Latest Evolution Of Floseal At AORN Meeting

Baxter Unveils The Latest Evolution Of Floseal At AORN Meeting

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced that it has received U.

Baxter To Host Webcast Of Annual Meeting Of Stockholders

Baxter To Host Webcast Of Annual Meeting Of Stockholders

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a webcast of its Annual Meeting of Stockholders on Tuesday, May 7, 2019 at 9 a.

Baxter Highlights Advancements In Clinical Nutrition At ASPEN Conference

Baxter Highlights Advancements In Clinical Nutrition At ASPEN Conference

Baxter International Inc. (NYSE:BAX), a global leader in clinical nutrition, today announced it will launch Clinolipid (20% Lipid Injectable Emulsion), its proprietary olive oil-based lipid emulsion, in the U.

Baxter To Host First Quarter 2019 Financial Results Conference Call For Investors

Baxter To Host First Quarter 2019 Financial Results Conference Call For Investors

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its first quarter 2019 financial results on Thursday, April 25, 2019, at 7:30 a.

Baxter Announces U.S. FDA Approval And Launch Of Ready-to-Use Cardiovascular Medicine Eptifibatide

Baxter Announces U.S. FDA Approval And Launch Of Ready-to-Use Cardiovascular Medicine Eptifibatide

Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced the U.

Baxter Honored As A 2019 "Top Company For Executive Women" By The National Association For Female Executives

Baxter Honored As A 2019 "Top Company For Executive Women" By The National Association For Female Executives

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today that it has been named one of the 2019 NAFE Top Companies for Executive Women by the National Association for Female Executives (NAFE).

Baxter Declares Quarterly Dividend

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.

Baxter To Present At The Barclays Global Healthcare Conference

Baxter To Present At The Barclays Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Barclays Global Healthcare Conference in Miami, Fla.

Baxter To Present At The Raymond James 40th Annual Institutional Investors Conference

Baxter To Present At The Raymond James 40th Annual Institutional Investors Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Raymond James 40th Annual Institutional Investors Conference in Orlando, Fla.

Baxter Reports 2018 Fourth-Quarter And Full-Year Results

Baxter Reports 2018 Fourth-Quarter And Full-Year Results

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the fourth quarter and full year ended Dec.

Baxter To Present At The 8th Annual SVB Leerink Global Healthcare Conference

Baxter To Present At The 8th Annual SVB Leerink Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 8th Annual SVB Leerink Global Healthcare Conference in New York, NY on Thursday, February 28, 2019.

Baxter's Sharesource Remote Patient Management Platform Has Logged More Than 5 Million Home Peritoneal Dialysis Treatments Globally; Milestone Is Evidence That Smarter, More Effective Innovation Is Enhancing Renal Care. (Photo: Business Wire)

Baxter's Sharesource Remote Patient Management Platform Has Logged More Than 5 Million Home Peritoneal Dialysis Treatments Globally; Milestone Is Evidence That Smarter, More Effective Innovation Is Enhancing Renal Care. (Photo: Business Wire)

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced the Sharesource remote patient management platform has performed more than 5 million home peritoneal dialysis (PD) treatments globally.

Baxter Has Started The U.S. Clinical Trial For Its Latest Peritoneal Dialysis Technology Designed To Generate Solution On Demand In Homes.

Baxter Has Started The U.S. Clinical Trial For Its Latest Peritoneal Dialysis Technology Designed To Generate Solution On Demand In Homes.

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today that the first patients have been enrolled in a U.

TheStreet Quant Rating: B+ (Buy)